Conversation
Impressive results from Novartis. Ganaplacide targets a novel mechanism that bypasses artemisinin resistance, which is critical as resistance mutations continue to spread.
Thatโs massive. 97% cure rate and kills resistant strains? Huge win for malaria treatment.
My Dad once had a "mild" case of malaria (he was on quinine as a preventative) & a "mild" case of the Flu at the same time.
He said that he was so sick that he *actually* thought he was going to die.
Malaria is serious stuff!
great to have another option, but standard care already cures "94%" of cases, so this is an incremental movement. But again, great to have more options and variable mechanisms.
This does look like maybe an improvement over current treatments, but it's not earth shattering. It's incremental. The foe is not vanquished. It's just slightly weaker now. And all this is assuming you believe those numbers and that they bear out in the real world.
The real shame is that you have to wait until *next year* rather than right fucking now
So what is this "entirely novel mechanism" they write about?
- let's see how you answer this, and how your answer compares to
Very exciting. Now has expanded use case. People forget high income countries buy as well for travel
Now, letโs go in for the kill by developing the economy and creating a middle class.
Quote
aaronshem
@aaronshem
Replying to @Craig_A_Spencer
You know what would really prevent the spread of diseases? Industrial scale power production as that people can afford single family homes, refrigeration, plumbing, individual bedrooms, screened windows, cattle industry that provides better nutrition & draws mosquitoes from x.com/aaronshem/statโฆ
Show moreIncredible progress elsewhere. Meanwhile, UK underfunding just pushes our best minds abroad. Until we fix that, we'll keep losing out on biotech breakthroughs like this.
Discover Wayfair Open Box and save big on like-new furniture and dรฉcor
*Warbled constipated voice*
That treatment interferes with wifi and makes people liberals.
GIF